Shanghai Keensea Medical Co., Ltd., established in 2021, is invested by Hong Kong-listed Keensea International (HK2225) with registered capital of 30 million RMB. The company specializes in minimally invasive surgery solutions, covering R&D, production, sales, and service. Products include 4K ultra-...